From: Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia
Characteristic | Group 3 PH (n = 2236) | Controls (n = 2236) | P value |
---|---|---|---|
Age at index date, mean (SD), y | 67.0 (14.4) | 71.0 (11.7)a | <.001b |
Age group, y | |||
18–30 | 34 (1.5) | 9 (0.4) | |
31–45 | 134 (6.0) | 49 (2.2) | |
46–65 | 841 (37.6) | 596 (26.7) | |
66–85 | 1035 (46.3) | 1383 (61.9) | |
>86 | 192 (8.6) | 199 (8.9) | |
Sex | |||
Female | 1433 (64.1) | 1300 (58.1) | <.001c |
Male | 803 (35.9) | 936 (41.8) | |
US census region | |||
North Central | 758 (33.9) | 933 (41.7) | <.001c |
Northeast | 344 (15.4) | 260 (11.6) | |
South | 722 (32.3) | 669 (29.9) | |
West | 401 (17.9) | 372 (16.7) | |
Unknown | 11 (0.5) | 2 (0.09) | |
Health plan type | |||
Comprehensive | 879 (39.3) | 1368 (61.2) | <.001c |
Health maintenance organization | 241(10.8) | 218 (9.8) | |
Point-of-service | 136 (6.1) | 101 (4.5) | |
Preferred provider organization | 866 (38.7) | 505 (22.6) | |
Others | 114 (5.1) | 44 (2.0) | |
CCId, mean (SD) | 2.80 (2.02) | 2.09 (1.70) | <.001b |
Underlying lung disease | |||
COPD | 1590 (71.1) | 1590 (71.1) | |
Interstitial lung disease | 438 (19.6) | 438 (19.6) | |
Sleep disorder breathing | 340 (15.2) | 340 (15.2) | |
Developmental lung disease | 503 (22.5) | 502 (22.5) | |
Alveolar hyperventilation disorder | 6 (0.2) | 7 (0.3) |